相关实验视频

Updated: Jun 15, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

电离性水减少了感染Leishmania amazonensis的BALB/c小鼠的伤害

Karina Miyuki Retamiro¹, Karine Campos Nunes¹, Aline Pinto Zani¹

¹Laboratory of Technological Innovation in the Development of Pharmaceuticals and Cosmetics, State University of Maringá, Maringá, Brazil.

|July 6, 2023

概括

电离性水可能有助于治愈由Leishmania寄生虫引起的皮肤病变. 研究表明,它在小鼠中减少了病变体积,而不会对血液因子产生不良影响.

科学领域:

* 生物医学研究
*热带疾病研究研究.
* 净水技术净水技术

背景情况:

* 电离性水 (IAW) 是由净水器产生的,可以支持组织修复.
*由于IAW的性,由于矿物盐和磁场处理,是无毒的,可能会延长存活时间.
*皮肤莱什曼病是一种热带疾病,会导致皮肤病变.

研究的目的:

* 评估IAW对Leishmania amazonensis诱导的皮肤雷什曼病的进展的影响.
* 为了比较小鼠饮用自来水 (TW) 与IAW的疾病演变.
* 评估IAW对血液参数的毒理影响.

主要方法:

*BALB/c小鼠感染了L. amazonensis,并在感染前30天和感染后4周内提供TW或IAW.
*小组还接受了抗莱什曼尼药物米尔特福辛作为对照.
* 在采集的血液和血样本上进行了生物化学测试和血液学测试.

主要成果:

* 在食用IAW的小鼠中观察到损伤体积的显著减少.
*IAW消费似乎抑制了脚中的病变发展.
* 血液学和白血谱检测显示正常值,表明IAW对血液因子没有毒性影响.

结论:

* 在皮肤雷什曼病的小鼠模型中,消耗电离性水显著降低了病变体积.
*IAW显示具有保护作用,有利于皮肤病变的不演变.
*IAW是一种安全的饮用水替代品,对小鼠的血液参数没有可观察到的毒性影响.

更多相关视频

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

相关概念视频

Leishmaniasis

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...